Kuala Lumpur Kepong Bhd (2445)
Bursa Malaysia · Malaysia · prices in MYR · close of 27 Oct 2026
Key indicators
| Last close | MYR 20.52 |
|---|---|
| 52-week range | 18.60 – 23.18 |
| Return, 1 month / 3 months | −8.9% / −1.4% |
| Return, 1 year / 3 years | +1.1% / +1.0% |
| Trend | Below its 200-day average |
| RSI (14) | 43 |
| Volatility (1 year) | 23.6% |
| Worst drawdown (1 year) | -14.8% |
| Average daily value traded | 18.22M MYR |
| Dividend yield | 2.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Kuala Lumpur Kepong is a Malaysian plantation company whose main business is cultivating oil palm and rubber on estates in Malaysia and Indonesia. It processes the harvested fruit into crude palm oil and palm kernel, and runs refineries and oleochemical plants that turn these into ingredients used by food, cosmetics and industrial customers. The company also has interests in property and retail, and is based in Malaysia.
Kuala Lumpur Kepong Bhd trades under the code 2445 on the Bursa Malaysia in Malaysia, with its price quoted in Malaysian ringgit (MYR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Kuala Lumpur Kepong Bhd (2445) trades on the Bursa Malaysia in Malaysia. It last closed at MYR 20.52 on 27 October 2026.
Its price-based Market X-Ray is 75 out of 100 (a strong price profile), ranking 95 of 1,066 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 1.1% and over the last three months it fell 1.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Bursa Malaysia
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 72 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | -1.2% | ||
| From 52-week high | -10.4% | ||
| Momentum | 65 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -1.4% | ||
| 6-month return | 0.5% | ||
| 12-month return, skipping the last month | 11.0% | ||
| Stability (higher is calmer) | 86 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 23.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -14.8% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 18.22M MYR | ||
| Zero-volume days | 5.0% | ||
| Income | 49 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.9% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +3.7% |
|---|---|
| 1 month | −8.9% |
| 3 months | −1.4% |
| 6 months | +0.5% |
| 1 year | +1.1% |
| 3 years | +1.0% |
| 5 years | +8.7% |
Signals
| 50-day / 200-day average | 21.68 / 20.76 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 0.54 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 9 Jul 2026 | MYR 0.2000 |
| 29 Jan 2026 | MYR 0.4000 |
| 9 Jul 2025 | MYR 0.2000 |
| 28 Jan 2025 | MYR 0.4000 |
| 5 Jul 2024 | MYR 0.2000 |
| 30 Jan 2024 | MYR 0.4000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Bursa Malaysia; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.